• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·MMED
Held by 2 Gurus
Share

MiniMed Group, Inc. Stocks

$ 18.29Last Updated 22.10.2026

Issuer Rating

4/7
Performance

Modest

Risk

Moderate

Recommendation

Hold

Market Cap

$ 5.06B

$ 18.29
Key Takeaways

Risk factor

Considerable default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

-0.02%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%-0.02%

Latest news

08.03.2026 22:00

Vendor placement for Patriot, record PayPay listing: what's important about IPOs by March 8

06.03.2026 15:00

MiniMed IPO: diabetes monitoring device maker goes public

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Company Valuation

Slightly overvalued
3/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.10.2026 18:44

U.S. stocks fell at the opening bell, and the price of Brent crude oil exceeded $115

23.10.2026 18:36

Jensen Huang: “Today, I’m even more enthusiastic about AI than I was a year ago.”

23.10.2026 17:55

Shares of biotech company Biohaven have soared: its drug is closer to approval. Has the upside been exhausted?

23.10.2026 17:19

A Portfolio for a Changing Economy: JPMorgan Proposes an Alternative to the 60/40 Strategy

23.10.2026 16:54

SpaceX wants to become a major telecommunications provider in the U.S. Which stocks should you keep an eye on?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026